Literature DB >> 29595203

nCVTs: a hybrid smart tumour targeting platform.

Wei Jiang Goh1, Shui Zou, Bertrand Czarny, Giorgia Pastorin.   

Abstract

A hybrid drug delivery platform involving the fusion of cell membranes from U937 monocytes and synthetic lipids to create nano-cell vesicle technology systems (nCVTs) is designed. nCVTs are engineered for a targeted approach towards tumour sites by preserving key surface proteins from U937 monocytes, while being amendable to functionalization and loading due to their liposomal components.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29595203     DOI： 10.1039/c7nr08720a

Source DB:  PubMed          Journal:  Nanoscale        ISSN： 2040-3364            Impact factor:   7.790


  4 in total

1.  Cell-Derived Nanovesicles as Exosome-Mimetics for Drug Delivery Purposes: Uses and Recommendations.

Authors:  Yi-Hsuan Ou; Shui Zou; Wei Jiang Goh; Jiong-Wei Wang; Matthias Wacker; Bertrand Czarny; Giorgia Pastorin
Journal:  Methods Mol Biol       Date:  2021

2.  Genetically Engineered MRI-Trackable Extracellular Vesicles as SARS-CoV-2 Mimetics for Mapping ACE2 Binding In Vivo.

Authors:  Andrea Galisova; Jiri Zahradnik; Hyla Allouche-Arnon; Mattia I Morandi; Paula Abou Karam; Michal Fisler; Ori Avinoam; Neta Regev-Rudzki; Gideon Schreiber; Amnon Bar-Shir
Journal:  ACS Nano       Date:  2022-08-03       Impact factor: 18.027

3.  Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles.

Authors:  Yi-Hsuan Ou; Jeremy Liang; Wei Heng Chng; Ram Pravin Kumar Muthuramalingam; Zi Xiu Ng; Choon Keong Lee; Yub Raj Neupane; Jia Ning Nicolette Yau; Sitong Zhang; Charles Kang Liang Lou; Chenyuan Huang; Jiong-Wei Wang; Giorgia Pastorin
Journal:  Pharmaceutics       Date:  2022-08-20       Impact factor: 6.525

Review 4.  Tumor microenvironment responsive drug delivery systems.

Authors:  Qunye He; Jun Chen; Jianhua Yan; Shundong Cai; Hongjie Xiong; Yanfei Liu; Dongming Peng; Miao Mo; Zhenbao Liu
Journal:  Asian J Pharm Sci       Date:  2019-09-26       Impact factor: 6.598
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.